Product NDC: | 0591-2880 |
Proprietary Name: | Verapamil Hydrochloride |
Non Proprietary Name: | verapamil hydrochloride |
Active Ingredient(s): | 120 mg/1 & nbsp; verapamil hydrochloride |
Administration Route(s): | ORAL |
Dosage Form(s): | CAPSULE, DELAYED RELEASE PELLETS |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 0591-2880 |
Labeler Name: | Watson Laboratories, Inc. |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | NDA019614 |
Marketing Category: | NDA |
Start Marketing Date: | 19900529 |
Package NDC: | 0591-2880-01 |
Package Description: | 100 CAPSULE, DELAYED RELEASE PELLETS in 1 BOTTLE, PLASTIC (0591-2880-01) |
NDC Code | 0591-2880-01 |
Proprietary Name | Verapamil Hydrochloride |
Package Description | 100 CAPSULE, DELAYED RELEASE PELLETS in 1 BOTTLE, PLASTIC (0591-2880-01) |
Product NDC | 0591-2880 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | verapamil hydrochloride |
Dosage Form Name | CAPSULE, DELAYED RELEASE PELLETS |
Route Name | ORAL |
Start Marketing Date | 19900529 |
Marketing Category Name | NDA |
Labeler Name | Watson Laboratories, Inc. |
Substance Name | VERAPAMIL HYDROCHLORIDE |
Strength Number | 120 |
Strength Unit | mg/1 |
Pharmaceutical Classes | Calcium Channel Antagonists [MoA],Calcium Channel Blocker [EPC] |